Roche Diagnostics announces ground breaking partnership discussions with Government to transform cancer testing in patients

Added: Over a year ago by Roche

Diagnosing conditions such as cancer could be transformed as a result of innovative partnerships between Roche Diagnostics, the Government, NHS and academia to create the digital tissue laboratory of the future.

The UK Government has announced, as part of its Life Sciences sector deal, that it’s in discussion with Roche Diagnostics and partners to support the mainstream implementation of Digital Pathology services across the NHS. This investment could see the trialling of a new, innovative approach to cancer testing that includes whole slide scanners, image management software and image analysis algorithms for use within the NHS.

The current shortage of pathologists and geographic constraints can make it difficult or lengthy for an expert to provide an opinion on a cancer patient case. Once important patient cases are made available digitally, experts from any location can review them without delay. This means more equal access to experts to provide a timely and accurate diagnosis for cancer patients.

Additionally, making more information available electronically opens possibilities for the discovery of new treatments and the development of Artificial Intelligence algorithms in Pathology diagnosis. Overall, patient care could be transformed by this partnership as the greater efficiency in tissue pathology services will help deliver faster and more accurate test results across the NHS.

Commenting on the announcement, Geoff Twist, Managing Director of Roche Diagnostics UK & Ireland, said:

“Roche Diagnostics is proud to be working with the Government at what is an incredibly exciting time for the future of our NHS.

“For a number of years, Roche has led the way in advances in medicines and diagnostics and we take great pride in our collaborative working relationship with the Government and NHS to deliver the best possible solutions in patient care.

“Today’s announcement from the Government could help transform tissue pathology services and pave the way for the UK to create a new global industry with Artificial Intelligence and Digital Pathology at its forefront. We are committed to helping the Government moving forward.”